Zeiss Merges Its Ophthalmic Systems With Asclepion And Reports Record Results

The reorganization of Zeiss' vision care activities goes on. The Carl Zeiss Group has signed an agreement in principle to merge its ophthalmology equipment business unit, including its ophthalmic systems operations in Jena, Germany and Dublin, California, with Asclepion-Meditec, a public German company based also in Jena.

To continue reading this article register now.

Already an Eyewear Intelligence subscriber? Sign in here.


Become a member today for full access from just €7,29 a week!

Buying a membership today will give you:

  • Unlimited access to ewintelligence.com - all insight and analysis available online
  • Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
  • Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
  • Case studies and best practices on business challenges
  • Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
  • Access to over 11,500 articles and analyses in the archive
  • Personal library to save articles and track your key content
  • Powerful search and intuitive navigation

Or sign-up for a trial month for just 9,90€. To continue reading this article register now.